Aandeel OVASCIENCE INC
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen OvaScience Inc Nasdaq

Aandelen

US69014Q1013

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Millendo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Millendo Therapeutics, Inc. and Tempest Therapeutics, Inc. Enter into First Amendment to Loan and Security Agreement
Millendo Therapeutics, Inc. Joins Nicholas Maestas as Vice President, Strategy and Finance and It's Principal Financial Officer
TEMPEST THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Tempest Therapeutics : BUSINESS (Form 8-K)
TEMPEST THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Tempest Therapeutics : to Participate in William Blair 2021 Biotech Focus Conference
TEMPEST THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
Tempest Therapeutics : to Participate in William Blair 2021 Biotech Focus Conference
TEMPEST THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Millendo Therapeutics : Amendment to Current Report (SEC Filing - 8-K/A)
Tempest Therapeutics : MILLENDO THERAPEUTICS, INC. Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K/A)
Millendo Therapeutics : Tempest Closes Merger with Millendo and Completes PIPE Financing (Form 8-K)
Millendo Therapeutics, Inc.(NasdaqCM:MLND) dropped from NASDAQ Composite Index
Tempest Therapeutics Inc. completed the acquisition of Millendo Therapeutics, Inc. in a reverse merger transaction for approximately $180 million.
Millendo Therapeutics : Tempest and Millendo Announce Stockholder Approval of Merger (Form 8-K)
MILLENDO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
Millendo Therapeutics : , Tempest Therapeutics Investors Approve Merger Proposals
MILLENDO THERAPEUTICS, INC. : Other Events (form 8-K)
MILLENDO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers MLND
  4. Koers
  5. Nieuws OvaScience Inc
  6. Andere talen